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SUPPORTING MND PATIENTS USING NIV: EXPERIENCES OF 
PROFESSIONAL CAREGIVERS 
Background Regular administration of positive pressure non-invasive ventilation (NIV), 
typically at night to ameliorate nocturnal hypoventilation, extends survival without halting 
disease progression (1).  Many people with MND need practical support to benefit from NIV 
treatment beyond that which can be provided by family caregivers. There is a paucity of 
research describing formal care support in MND in general, and very little knowledge of the 
work of professionals supporting NIV treatment in any context.  
Objectives To understand how professional caregivers support NIV treatment in MND. 
Methods A qualitative approach was used to facilitate exploration and description of formal 
support of NIV treatment by a variety of health and social care professionals who, as a part of 
their job, provide support for MND patients using NIV. The semi-structured interview 
schedule included knowledge of MND symptoms, familiarity with NIV treatment, practical 
support, expectations, and a critical assessment of NIV treatment and their ability to support 
NIV treatment. The analysis was essentially explanation building, towards seeing common 
patterns, and ultimately providing recommendations. 
Results Seventeen professionals consented, including GPs, community and respiratory 
physiotherapists, speech and language therapists (SLTs), community nurses and nursing 
home/care agency staff. GPs, community physiotherapists and SLTs reported very few cases 
in their practices but had knowledge of NIV treatment, in contrast to community nurses and 
nursing home/care agency staff, who typically have neither knowledge nor experience until 
faced with a patient using NIV. Practical support provided by professionals included advice, 
titrating pressure, assistance for those unable to use the equipment independently, and 
psychological support. 
Discussion Attitudes and expectations of NIV differed, with some professionals being 
concerned about symptom relief, some about functional improvements (such as improved 
speech), and some with operational issues (such as mask comfort), without considering the 
worth of NIV as a treatment. Some professionals who are responsible for the daily care of 
patients using NIV report no education about NIV in advance of meeting such patients, and 
so typically learn about NIV treatment ‘on-the-job’. 
Conclusions  Professional carers were very disparate in their attitudes and their background 
training in MND and NIV. There is a need to examine training requirements for nursing 
home/care agency staff. Furthermore, professionals showed no consensus on the benefits of 
NIV but were fulfilling their professional duties to administer and sustain it without 
knowledge or involvement in the decision to commence it. 
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